Thomas B. Shima
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
-
- Protease and Inhibitor Mechanisms
Papers in
- Oncology 6
- HER2/EGFR in Cancer Research 3
- Cancer Cells and Metastasis 2
- PARP inhibition in cancer therapy 2
-
- TGF-β signaling in diseases 1
- Cancer therapeutics and mechanisms 1
- Wnt/β-catenin signaling in development and cancer 1
- Co-authors
- Erik W. Thompson (5 shared papers)Robert B. Dickson (4 shared papers)Gerhard Zugmaier (2 shared papers)George R. Martin (2 shared papers)Marc E. Lippman (2 shared papers)Steven Donahue (1 shared paper)Nils Brünner (1 shared paper)Robert Clarke (1 shared paper)
- Journals
- Annals of the New York Academy of Sciences (1 paper)Biochemical and Biophysical Research Communications (1 paper)Journal of Cellular Physiology (1 paper)Journal of Investigative Dermatology (1 paper)PubMed (4 papers)
- Partner nations
- United States
In The Last Decade
Thomas B. Shima
9 papers receiving 572 citations
Peers
Comparison fields: 5 of 77
- Immunology and Allergy 103
- Cancer Research 140
- Oncology 223
- Cell Biology 113
- Molecular Biology 331
Countries citing papers authored by Thomas B. Shima
This map shows the geographic impact of Thomas B. Shima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas B. Shima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas B. Shima more than expected).
Fields of papers citing papers by Thomas B. Shima
This network shows the impact of papers produced by Thomas B. Shima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas B. Shima. The network helps show where Thomas B. Shima may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas B. Shima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 448 | |
| 2 | ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. | 1989 | 34 |
| 3 | 1995 | 29 | |
| 4 | Carzinophilin, a new tumor inhibitory substance produced by streptomyces. I. | 1954 | 28 |
| 5 | Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. | 1988 | 24 |
| 6 | Studies on antitumor activity of mitomycin. | 1957 | 15 |
| 7 | 1994 | 4 | |
| 8 | 1990 | 4 | |
| 9 | Regulation of invasiveness of human breast cancer cell lines in vitro. | 1988 | 1 |
About Thomas B. Shima
Thomas B. Shima is a scholar working on Oncology, Molecular Biology, Genetics, Cardiology and Cardiovascular Medicine and Toxicology, having authored 9 papers that have together received 587 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Cancer Cells and Metastasis (2 papers), PARP inhibition in cancer therapy (2 papers), Estrogen and related hormone effects (2 papers), TGF-β signaling in diseases (1 paper), Synthesis and Biological Activity (1 paper), Cancer therapeutics and mechanisms (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). The work is most often cited by research in Immunology and Allergy (103 citations), Cancer Research (140 citations), Oncology (223 citations), Cell Biology (113 citations) and Molecular Biology (331 citations). Thomas B. Shima has collaborated with scholars based in United States. Frequent co-authors include Erik W. Thompson, Robert B. Dickson, Gerhard Zugmaier, George R. Martin, Marc E. Lippman, Steven Donahue, Nils Brünner, Robert Clarke, Soonmyoung Paik and Jeffrey A. Torri. Their work appears in journals such as Annals of the New York Academy of Sciences, Biochemical and Biophysical Research Communications, Journal of Cellular Physiology, Journal of Investigative Dermatology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.